ImmuPharma
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus (NCT03427151) | ImmuPharma | 2018-02-27 |
Track ImmuPharma automatically
Every clearance here is in the API, with alerts when new ones post.